Picture of Precision Biosciences logo

DTIL — Precision Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Precision BioSciences Inc reports results for the quarter ended in September 30 - Earnings Summary

* Precision BioSciences Inc  DTIL.OQ  reported a quarterly
adjusted loss of $2.25​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of $-2.10.  The mean expectation of
six analysts for the quarter was for a loss of $1.92 per share.
Wall Street expected results to range from $-3.27 to -79 cents
per share.
    * Revenue fell 95.6% to $576.00 thousand from a year ago;
analysts
expected $6.36 million. 
    * Precision BioSciences Inc's reported EPS for the quarter
was a
loss of $2.25​.
    * The company reported a quarterly loss of $16.43 million.
    * Precision BioSciences Inc shares had risen by 0.7% this
quarter and lost 17.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Precision
BioSciences Inc is $30.00 
This summary was machine generated from LSEG data November 4 at
03:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.92          -2.25          Missed
 Jun. 30 2024      -1.50          4.67           Beat
 Mar. 31 2024      -1.91          -0.35          Beat
 Dec. 31 2023      -2.05          -4.06          Missed

Recent news on Precision Biosciences

See all news